Company information:
Drug Delivery International Limited (No: SC382118)
Status: Active
Incorporated: 19-Jul-2010
Accounts Next Due: 31-Aug-2024
Next Confirmation Statement Due: 08-Feb-2024
Industry Class: 72190 - Other research and experimental development on natural sciences and engineering
Current Director: GLENN CROCKER ( DOB: Mar-1964 From: May-2022 )
Current Director: GLENN CROCKER ( DOB: Mar-1964 From: May-2022 )
Current Director: LAURA GOW ( DOB: Jul-1984 From: Aug-2022 )
Current Director: JOANNE KELLEY ( DOB: Oct-1959 From: May-2022 )
Current Director: CLAIRE ELIZABETH MADDEN-SMITH ( DOB: Mar-1973 From: May-2022 )
Current Director: CLAIRE ELIZABETH MADDEN-SMITH ( DOB: Mar-1973 From: May-2022 )
Current Director: HOWARD NORMAN ERNEST STEVENS ( From: Aug-2010 )
Current Director: CAROL CHRISTINE THOMSON ( DOB: Jul-1974 From: Aug-2010 )
Current Director: CAROL CHRISTINE THOMSON ( DOB: Jul-1974 From: Aug-2010 )
Resigned Director: STEPHEN BROWN ( DOB: Feb-1958 From: May-2022 To: Dec-2023 )
Resigned Director: COLETTE FRANCES BROWN ( From: Jul-2010 To: Aug-2010 )
Resigned Director: LEE ANN HODGES ( From: Jul-2013 To: Aug-2014 )
Resigned Director: FIONA JANE MACDOUGALL ( From: Jul-2013 To: Jan-2018 )
Resigned Director: ALEXANDER BALFOUR MULLEN ( DOB: Mar-1968 From: Aug-2010 To: Aug-2017 )
Resigned Director: IAN STILLIE ( DOB: Oct-1961 From: Aug-2010 To: Aug-2013 )
Resigned Secretary: LEE ANN HODGES ( From: Jul-2013 To: Aug-2014 )
Persons of Significant Control:
Bio-Images Drug Delivery Ltd, Bio-Imaging Centre Basement Medical Block, Glasgow Royal Infirmary 84 Castle Street, Glasgow, G4 0SF, Scotland: Ownership of shares – 75% or more (Notified: 2016-04-06)
Company Accounts Summary (£)
| Item | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | Chart |
|---|---|---|---|---|---|---|---|---|---|
| Fixed assets | 98,553 | 427,185 | 675,599 | 804,427 | 842,380 | 992,665 | 945,329 | 931,653 | 98553.0,427185.0,675599.0,804427.0,842380.0,992665.0,945329.0,931653.0 |
| Fixed assets / Intangible assets | 51,813 | 147,683 | 260,575 | 370,248 | 494,406 | 571,105 | 629,158 | 671,127 | 51813.0,147683.0,260575.0,370248.0,494406.0,571105.0,629158.0,671127.0 |
| Fixed assets / Property, plant and equipment | 46,740 | 279,502 | 415,024 | 434,179 | 347,974 | 421,560 | 316,171 | 260,526 | 46740.0,279502.0,415024.0,434179.0,347974.0,421560.0,316171.0,260526.0 |
| Current assets | 531,079 | 1,003,894 | 377,828 | 224,710 | 266,147 | 107,085 | 95,874 | 76,466 | 531079.0,1003894.0,377828.0,224710.0,266147.0,107085.0,95874.0,76466.0 |
| Current assets / Debtors | 171,791 | 956,245 | 301,932 | 205,909 | 249,880 | 106,393 | 85,562 | 69,950 | 171791.0,956245.0,301932.0,205909.0,249880.0,106393.0,85562.0,69950.0 |
| Current assets / Cash at bank and on hand | 359,288 | 47,649 | 75,896 | 18,801 | 16,267 | 692 | 10,312 | 6,516 | 359288.0,47649.0,75896.0,18801.0,16267.0,692.0,10312.0,6516.0 |
| Net current assets (liabilities) | 77,680 | -921 | 107,918 | -133,887 | -304,894 | -473,024 | -541,000 | -650,348 | 77680.0,-921.0,107918.0,-133887.0,-304894.0,-473024.0,-541000.0,-650348.0 |
| Total assets less current liabilities | 176,233 | 426,264 | 783,517 | 670,540 | 537,486 | 519,641 | 404,329 | 281,305 | 176233.0,426264.0,783517.0,670540.0,537486.0,519641.0,404329.0,281305.0 |
| Provisions for liabilities, balance sheet subtotal | 9,348 | 4,831 | 58,973 | 63,808 | 9348.0,4831.0,58973.0,0.0,0.0,0.0,0.0,63808.0 | ||||
| Net assets (liabilities) | 166,885 | 242,191 | 593,100 | 586,894 | 501,638 | 412,690 | 326,024 | 167,587 | 166885.0,242191.0,593100.0,586894.0,501638.0,412690.0,326024.0,167587.0 |
| Equity / share capital and reserves | 166,885 | 242,191 | 593,100 | 586,894 | 501,638 | 412,690 | 326,024 | 167,587 | 166885.0,242191.0,593100.0,586894.0,501638.0,412690.0,326024.0,167587.0 |